CN104557897B - 法舒地尔‑硫辛酸二联体的合成及其应用 - Google Patents
法舒地尔‑硫辛酸二联体的合成及其应用 Download PDFInfo
- Publication number
- CN104557897B CN104557897B CN201410152907.XA CN201410152907A CN104557897B CN 104557897 B CN104557897 B CN 104557897B CN 201410152907 A CN201410152907 A CN 201410152907A CN 104557897 B CN104557897 B CN 104557897B
- Authority
- CN
- China
- Prior art keywords
- fasudil
- compound
- lipoic acid
- dyad
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410152907.XA CN104557897B (zh) | 2014-04-10 | 2014-04-10 | 法舒地尔‑硫辛酸二联体的合成及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410152907.XA CN104557897B (zh) | 2014-04-10 | 2014-04-10 | 法舒地尔‑硫辛酸二联体的合成及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104557897A CN104557897A (zh) | 2015-04-29 |
CN104557897B true CN104557897B (zh) | 2017-10-27 |
Family
ID=53075066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410152907.XA Active CN104557897B (zh) | 2014-04-10 | 2014-04-10 | 法舒地尔‑硫辛酸二联体的合成及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104557897B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107382987A (zh) * | 2017-07-19 | 2017-11-24 | 佛山市第五人民医院 | 一种具有预防和治疗创伤性脑损伤活性的化合物及其制备方法和用途 |
CN116375685B (zh) * | 2023-03-29 | 2023-12-12 | 沈阳药科大学 | 一种法舒地尔衍生物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006115247A1 (ja) * | 2005-04-25 | 2006-11-02 | D. Western Therapeutics Institute, Inc. | 高選択的Rhoキナーゼ阻害剤 |
CN101612157A (zh) * | 2008-06-26 | 2009-12-30 | 天津红日药业股份有限公司 | 法舒地尔诱导成年脑内源性神经干细胞再生的用途 |
CN103432118A (zh) * | 2013-08-30 | 2013-12-11 | 暨南大学 | 穿心莲内酯衍生物在制备预防和治疗神经退行性疾病药物中的应用 |
-
2014
- 2014-04-10 CN CN201410152907.XA patent/CN104557897B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006115247A1 (ja) * | 2005-04-25 | 2006-11-02 | D. Western Therapeutics Institute, Inc. | 高選択的Rhoキナーゼ阻害剤 |
CN101612157A (zh) * | 2008-06-26 | 2009-12-30 | 天津红日药业股份有限公司 | 法舒地尔诱导成年脑内源性神经干细胞再生的用途 |
CN103432118A (zh) * | 2013-08-30 | 2013-12-11 | 暨南大学 | 穿心莲内酯衍生物在制备预防和治疗神经退行性疾病药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104557897A (zh) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3835296A1 (en) | Ketoamide compound and preparation method, pharmaceutical composition, and use thereof | |
CN106946748B (zh) | 递送3-氨基-1-丙磺酸的方法、化合物、组合物和载体 | |
Chen et al. | Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms | |
EP3277675B1 (en) | Heterocyclic modulators of lipid synthesis | |
CN102250202B (zh) | 1-对硝基苯基-β-咔啉-3-甲酰氨基酸苄酯及其合成方法和应用 | |
CN107151250A (zh) | 嘧啶类七元环化合物、其制备方法、药用组合物及其应用 | |
CN110256313A (zh) | 一种光敏剂前药化合物及其制备方法和应用 | |
AU2015207867A1 (en) | Compounds and methods for the treatment of pain and other diseases | |
Li et al. | Synthesis and evaluation of nitric oxide-releasing derivatives of 3-n-butylphthalide as anti-platelet agents | |
CN104557897B (zh) | 法舒地尔‑硫辛酸二联体的合成及其应用 | |
JP2018502121A (ja) | トリフルオロアセトヒドラジド類化合物及びその調製方法並びに製薬における応用 | |
CN103848795B (zh) | 一种1,2,5-噁二唑-2-氧化物组蛋白去乙酰化酶抑制剂及其制备方法和应用 | |
CN103524559B (zh) | 多取代4-甲氨基苯甲脒的酯衍生物及其制备方法和用途 | |
WO2020244460A1 (zh) | 芳杂乙酰胺类衍生物及其制备和应用 | |
CN106892920A (zh) | 苦豆碱衍生物、其制备方法及用途 | |
CN106905193A (zh) | 芳酰基胍基奥司他韦羧酸衍生物及其制备方法和应用 | |
CN105646463B (zh) | 他克林-二甲胺基黄酮杂合物、制备方法及其应用 | |
CN105949180B (zh) | 治疗中枢神经系统退行性疾病的化合物及其应用 | |
CN105111195B (zh) | 他克林-联苯双酯杂合物、其制备方法及应用 | |
CN104203945B (zh) | 1,4‑二氢‑萘啶衍生物及其药物组合物和用途 | |
CN103933038B (zh) | 一组苦参碱类化合物用于制备抗肝纤维化和抗肝癌药物的应用 | |
CN107176956A (zh) | 一种ido抑制剂化合物、药用组合物、用途 | |
CN107827830B (zh) | 一种奥司他韦衍生物及其制备方法与应用 | |
CN106045972B (zh) | 咔唑-利凡斯的明二联体及其药物组合物和应用 | |
CN108239081A (zh) | 一种抑制rock的化合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Pi Rongbiao Inventor after: Chen Meihui Inventor after: Wen Shijun Inventor after: Liu Qi Inventor after: Zhou Shiyou Inventor after: Liu Anmin Inventor after: Liu Peiqing Inventor before: Pi Rongbiao Inventor before: Chen Meihui Inventor before: Wen Shijun Inventor before: Liu Qi Inventor before: Zhou Shiyou Inventor before: Liu Anmin Inventor before: Liu Peiqing |
|
GR01 | Patent grant | ||
GR01 | Patent grant |